EP 1265919 A2 20021218 - G-PROTEIN ASSOCIATED MOLECULES
Title (en)
G-PROTEIN ASSOCIATED MOLECULES
Title (de)
G-PROTEIN ASSOZIERTE MOLEKÜLE
Title (fr)
MOLECULES ASSOCIEES A LA PROTEINE G
Publication
Application
Priority
- US 0109220 W 20010322
- US 19163100 P 20000323
Abstract (en)
[origin: WO0170807A2] The invention provides human G-protein associated molecules (GPAM) and polynucleotides which identify and encode GPAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GPAM.
IPC 1-7
C07K 14/47; C12N 15/12; C12N 15/66; C12N 5/10; A01K 67/027; C07K 16/18; C12N 15/11; C12Q 1/68; A61K 38/17; A61P 37/00
IPC 8 full level
A61K 45/00 (2006.01); A61K 51/00 (2006.01); A61P 1/04 (2006.01); A61P 1/06 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 5/38 (2006.01); A61P 7/00 (2006.01); A61P 7/06 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 17/16 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 19/04 (2006.01); A61P 19/06 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 33/00 (2006.01); A61P 33/02 (2006.01); A61P 33/10 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); A61P 37/04 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/06 (2017.12); A61P 1/16 (2017.12); A61P 1/18 (2017.12); A61P 3/10 (2017.12); A61P 5/14 (2017.12); A61P 5/38 (2017.12); A61P 7/00 (2017.12); A61P 7/06 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 17/16 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/04 (2017.12); A61P 19/06 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 33/00 (2017.12); A61P 33/02 (2017.12); A61P 33/10 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/00 (2017.12); A61P 37/04 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07K 14/47 (2013.01); A01K 2217/05 (2013.01)
Citation (search report)
See references of WO 0170807A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0170807 A2 20010927; WO 0170807 A3 20020221; AU 4594301 A 20011003; CA 2402747 A1 20010927; EP 1265919 A2 20021218; JP 2004501610 A 20040122
DOCDB simple family (application)
US 0109220 W 20010322; AU 4594301 A 20010322; CA 2402747 A 20010322; EP 01918926 A 20010322; JP 2001569007 A 20010322